Kolexia
Michot Jean-Marie Médecine interne
Michot Jean-Marie
Médecine interne
Gustave-Roussy
Villejuif, France
407 Activités
1.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Lymphome B Lymphome malin non hodgkinien Lymphome B diffus à grandes cellules Myélome multiple Récidive tumorale locale COVID-19 Hépatite

Collaborateurs

Voir plus
Ribrag Vincent
Ribrag Vincent
Gustave-Roussy, Villejuif, France
Marabelle Aurelien
Marabelle Aurelien
Gustave-Roussy, Villejuif, France
Lambotte Olivier
Lambotte Olivier
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Champiat Stephane
Champiat Stephane
Gustave-Roussy, Villejuif, France

Industries

Voir plus
M3 Global Research Ltd
20 collaboration(s)
Dernière en 2023
ATHENEUM PARTNERS GMBH
6 collaboration(s)
Dernière en 2023
Amgen
5 collaboration(s)
Dernière en 2022
GSK
4 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.
Leukemia & lymphoma   03 mars 2024
Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
Cell death & disease   14 février 2024
Ulcères de jambes développés sous inhibiteurs de tyrosine kinase ciblant le récepteur du VEGF
Journées dermatologiques de Paris 2023   01 décembre 2023
Antibody drug conjugates in older patients: State of the art.
Critical reviews in oncology/hematology   24 novembre 2023
Efficacy and Safety of Golcadomide, a Novel Cereblon E3 Ligase Modulator (CELMoD) Agent, Combined with Rituximab in a Phase 1/2 Open-Label Study of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
65th ASH Annual Meeting Abstracts   02 novembre 2023
Odronextamab Demonstrates Durable Complete Responses in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Progressing after CAR-T Therapy: Outcomes from the ELM-1 Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
BMJ medicine   27 octobre 2023
A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapsed/Refractory DLBCL and iNHL.: A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 in Combination With Obinutuzumab (GA101) in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Indolent Non-Hodgkin's Lymphoma
Essai Clinique (Celgene)   19 octobre 2023
1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1845P Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023